In the BioHarmony Drug Report Database
Epoetin theta
Biopoin, Eporatio (epoetin theta) is a protein pharmaceutical. Epoetin theta was first approved as Biopoin on 2009-10-23. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.
Trade Name
|
Biopoin, Eporatio |
|---|---|
Common Name
|
epoetin theta |
ChEMBL ID
|
CHEMBL2108290 |
Indication
|
anemia, chronic kidney failure, neoplasms |
Drug Class
|
Erythropoietins |
Image (chem structure or protein)
